Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Matthew Loft"'
Autor:
Belinda Lee, Lucy Gately, Sheau Wen Lok, Ben Tran, Margaret Lee, Rachel Wong, Ben Markman, Kate Dunn, Vanessa Wong, Matthew Loft, Azim Jalili, Angelyn Anton, Richard To, Miles Andrews, Peter Gibbs
Publikováno v:
Cancers, Vol 14, Iss 17, p 4131 (2022)
Traditional cancer registries have often been siloed efforts, established by single groups with limited objectives. There is the potential for registry data to support a broad range of research, audit and education initiatives. Here, we describe the
Externí odkaz:
https://doaj.org/article/4a5f3038a4dd4774bea440d529c2d413
Publikováno v:
Journal of Personalized Medicine, Vol 9, Iss 3, p 37 (2019)
Pancreatic adenocarcinoma remains one of the most aggressive cancers with an ongoing dismal survival rate despite some recent advances in treatment options. This is largely due to the typically late presentation and limited effective therapeutic opti
Externí odkaz:
https://doaj.org/article/d3819f47737e412ca75f541efd5eb77a
Autor:
Matthew Loft, Sheau Wen Lok, Richard De Boer, Laeeq Malik, Sally Greenberg, Belinda Yeo, Angelyn Anton, Michelle Nottage, Vanessa Wong, Louise Nott, Ian M. Collins, Javier Torres, Frances Barnett, Janine M. Lombard, Peter Gibbs, Lucy Gately
Publikováno v:
Breast Cancer Research and Treatment. 198:67-74
Autor:
Matthew Y. Wei, Yasser Arafat, Margaret Lee, Suzanne Kosmider, Matthew Loft, Ian Faragher, Peter Gibbs, Justin M. Yeung
Publikováno v:
ANZ Journal of Surgery.
Autor:
Matthew Loft, Jeremy Shapiro, Margaret Lee, Rachel Wong, Jeanne Tie, Suzanne Kosmider, Vanessa Wong, Azim Jalali, Belinda Lee, Sumitra S. Ananda, Peter Gibbs
Publikováno v:
Internal Medicine Journal.
Treatment with cetuximab provides a survival benefit for patients with RAS wild-type metastatic colorectal cancer (mCRC). Practice-defining cetuximab studies utilised weekly (q1w) administration. More convenient second weekly (q2w) administration is
Autor:
Ian T. Jones, Matthew Loft, Jeanne Tie, Suzanne Kosmider, Ian Faragher, Margaret Lee, Peter Gibbs, Rachel Wong, Malcolm Steel, Hui-Li Wong, Matthew Croxford, Mario Guerrieri, Michael Christie
Publikováno v:
Internal Medicine Journal. 51:1262-1268
BACKGROUND: Neoadjuvant chemoradiation therapy is standard-of-care treatment for locally advanced rectal cancer (LARC). A pathological complete response (pCR) following chemoradiation therapy is an early indicator of treatment benefit and associated
Autor:
Yasser Arafat, Matthew Loft, Ke Cao, Fiona Reid, Suzanne Kosmider, Margret Lee, Peter Gibbs, Ian G. Faragher, Justin M Yeung
Publikováno v:
ANZ Journal of Surgery. 92:2784-2785
Autor:
Chia Yuen Chong, Azim Jalali, Hui Li Wong, Matthew Loft, Rachel Wong, Margaret Lee, Lucy Gately, Wei Hong, Jeremy Shapiro, Suzanne Kosmider, Jeannie Tie, Sumitra Ananda, Justin M Yeung, Brigette Ma, Matthew Burge, Ross Jennens, Ben Tran, Belinda Lee, Lionel Lim, Andrew Dean, Louise Nott, Peter Gibbs
Publikováno v:
Asia-Pacific journal of clinical oncologyREFERENCES. 18(5)
RAS mutation testing now routinely informs the optimal management of metastatic colorectal cancer (mCRC), specifically the finding of a RAS mutation defines patients who will not benefit from treatment with an epidermal growth factor receptor inhibit
Autor:
Azim Jalali, Jeanne Tie, Rachel Wong, Sarah J. Banks, Lucy Gately, Belinda Lee, Margaret Lee, Matthew Loft, Grace Gard, Catherine Dunn, Adnan Khattak, Hui-Li Wong, Ross Jennens, Justin M. C. Yeung, Peter Gibbs, Joseph McKendrick, Suzanne Kosmider, Sumitra Ananda, L. Lim, Jeremy Shapiro
Publikováno v:
Current problems in cancer. 46(2)
For patients with refractory metastatic colorectal cancer (mCRC) treatment with Trifluridine/Tipiracil, also known as TAS-102, improves overall survival. This study aims to investigate the efficacy and safety of TAS-102 in a real-world population fro
Publikováno v:
Internal Medicine Journal. 51:1367-1367